GSK has reached a settlement in another lawsuit related to its heartburn drug Zantac in California. The pharmaceutical company has been facing numerous legal challenges over the popular medication, which has been linked to potential cancer risks.
The settlement comes as part of GSK's efforts to address the litigation surrounding Zantac. The company has been proactive in resolving these legal matters to mitigate any further impact on its reputation and finances.